Cardiff Oncology, Inc.’s CRDF share price has surged by 15.07%, which has investors questioning if this is right time to sell ...
Hosted on MSN10mon
Cardiff (CRDF) Stock Rallies 194% in a Month: Here's WhyCardiff Oncology, Inc. CRDF is developing novel ... The massive surge in the stock price has been fueled by an encouraging update from the company’s developmental program for onvansertib in ...
Hosted on MSN2mon
Cardiff Oncology announces positive colorectal data and $40m stock oversubscriptionGlobalData is the parent company of Clinical Trials Arena. "Cardiff Oncology announces positive colorectal data and $40m stock oversubscription" was originally created and published by Clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback